Patent preparation, prosecution, and counseling for early stage medical device company developing a catheter-based treatment for diseases related to sympathetic hyperactivity, including hypertension, chronic kidney disease, metabolic syndrome and heart failure. Served as Ardian's IP counsel for several financing rounds, including a $47 million financing round in early 2009.